Related Experiment Video
Updated: Mar 18, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
[The third and new face of Chagas disease]
J-F Pays1,2
1CENPETROP - Faculté de médecine de Corrientes, Université dul Nordeste, Nordeste, Argentine. jeanfrancoispays@gmail.com.
Abstract:
After the publication of the results of the BENEFIT study concluding that the benznidazole (5 mg/kg/d/60 d) is ineffective to stop the progression of the established Chagas' cardiomyopathy in adults, the author evokes the new experiences and the new challenges of 2016 regarding Chagas disease while speculating on its future and by calling back some elements little known of his history, in particular the fact that it is Chagas who invented about it to some extent the concept of "neglected disease".
Related Concept Videos
Cholera
Cytomegalovirus Disease
Sexually Transmitted Infections
Bacterial Phylum Chlamydiae
Symbiosis
Reservoir of Infection

